Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials Research Progress in Prevention and Treatment of Diabesity and the Complications thereof by Dietary Fiber: A Literature Review Progress on Antimicrobial Peptides’Gene Endogenous Expression Regulation and Clinical Application Situation analysis for drug clinical trial institutions Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine